Span Diagnostic last traded at ₹21.00 (2026-10-13). Over the past month the stock moved -28.3%, three months the stock moved -42.7%, year the stock moved -25.6%. Its closing range over 52 weeks is ₹21.00 – ₹36.67, with the latest close 42.7% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1972, Span Divergent Ltd deals in different businesses through various subsidiaries.[1]
Business Overview:[1][2] SDL operates across multiple business segments through dedicated subsidiaries in the Food, Agriculture, and Life Sciences verticals. It also provides management consulting and support services, offering financial, technical, and operational expertise to its group entities. The company actively oversees compliance, networking, and business development activities, while closely monitoring subsidiary performance and implementing strategic guidance and corrective measures as approved by the Board.
In the latest quarter (Jun 2026), Span Diagnostic reported sales of ₹1.02 crore (-4.7%) and net profit of ₹-1.19 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 1.02 | -1.04 | -101.96 | -1.19 | -1.45 |
| Mar 2026 | 4.65 | -0.86 | -18.49 | -1.12 | -1.32 |
| Dec 2025 | 3.86 | -1.08 | -27.98 | -1.13 | -1.78 |
| Sep 2025 | 7.65 | 0.00 | 0.00 | -0.18 | -0.24 |
| Jun 2025 | 1.07 | -0.66 | -61.68 | -0.17 | -0.18 |
| Mar 2025 | 0.55 | -0.94 | -170.91 | -1.03 | -1.63 |
| Dec 2024 | 1.90 | -0.22 | -11.58 | -0.21 | -0.27 |
| Sep 2024 | 2.80 | 0.24 | 8.57 | 0.05 | 0.24 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -11.9% | -36.9% | -81.8% | -71.2% | +173.2% | +103.2% | +745.5% | -4.7% |
| Operating profit growth | +14.3% | -153.7% | -547.6% | -353.8% | -100.0% | – | – | – |
| Net profit growth | – | -450.0% | -217.0% | – | -460.0% | – | – | – |
| EPS growth | – | -222.7% | -197.0% | – | -200.0% | – | – | – |
| OPM % | 8.6% | -11.6% | -170.9% | -61.7% | 0.0% | -28.0% | -18.5% | -102.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Span Diagnostic reported sales of ₹17.23 crore (+92.3%) and net profit of ₹-2.95 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 17.23 | -2.59 | -15.03 | -2.95 | -3.44 |
| Mar 2025 | 8.96 | -0.65 | -7.25 | -1.28 | -1.68 |
| Mar 2024 | 12.33 | 1.39 | 11.27 | 0.79 | 1.79 |
| Mar 2023 | 12.52 | 1.10 | 8.79 | -5.42 | -9.25 |
| Mar 2022 | 13.09 | 0.42 | 3.21 | -10.15 | -17.94 |
| Mar 2021 | 7.40 | -2.24 | -30.27 | -6.16 | -10.23 |
| Mar 2020 | 9.38 | -5.78 | -61.62 | -8.61 | -14.23 |
| Mar 2019 | 24.14 | -7.20 | -29.83 | -14.05 | -22.28 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +65.7% | -61.1% | -21.1% | +76.9% | -4.4% | -1.5% | -27.3% | +92.3% |
| Operating profit growth | – | – | – | – | +161.9% | +26.4% | -146.8% | – |
| Net profit growth | – | – | – | – | – | – | -262.0% | – |
| EPS growth | – | – | – | – | – | – | -193.9% | – |
| OPM % | -29.8% | -61.6% | -30.3% | 3.2% | 8.8% | 11.3% | -7.3% | -15.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Span Diagnostic.
Get Free AI Stock Analysis FREE →Span Diagnostic Standalone June 2026 Net Sales at Rs 0.13 crore, down 65.02% Y-o-Y - Moneycontrol.com
Span Diagnostic Standalone June 2026 Net Sales at Rs 0.13 crore, down 65.02% Y-o-Y - Moneycontrol.com
Span Diagnostic shares were last quoted at ₹21.00 (-4.2% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Span Diagnostic has a price-to-earnings (P/E) ratio of 80.11 and a price-to-book (P/B) ratio of 1.58. The industry P/E is 45.16.
The 52-week high of Span Diagnostic is ₹51.49 and the 52-week low is ₹21.76.
The market capitalisation of Span Diagnostic is about ₹21.53 crore.
In the latest quarter (Jun 2026), Span Diagnostic reported sales of ₹1.02 crore (-4.7%) and net profit of ₹-1.19 crore, compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Span Diagnostic has 3-year profit growth of -38.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 48.13% of Span Diagnostic.
Span Diagnostic belongs to the Pharmaceuticals & Drugs sector.